title: Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
abstract: OBJECTIVE
  Different international target volume delineation guidelines exist and different treatment techniques are available for salvage radiation therapy (RT) for recurrent prostate cancer, but less is known regarding their respective applicability in clinical practice.
  
  
  METHODS
  A randomized phase III trial testing 64 Gy vs 70 Gy salvage RT was accompanied by an intense quality assurance program including a site-specific and study-specific questionnaire and a dummy run (DR). Target volume delineation was performed according to the European Organisation for the Research and Treatment of Cancer guidelines, and a DR-based treatment plan was established for 70 Gy. Major and minor protocol deviations were noted, interobserver agreement of delineated target contours was assessed, and dose-volume histogram (DVH) parameters of different treatment techniques were compared.
  
  
  RESULTS
  Thirty European centers participated, 43% of which were using 3-dimensional conformal RT (3D-CRT), with the remaining centers using intensity modulated RT (IMRT) or volumetric modulated arc technique (VMAT). The first submitted version of the DR contained major deviations in 21 of 30 (70%) centers, mostly caused by inappropriately defined or lack of prostate bed (PB). All but 5 centers completed the DR successfully with their second submitted version. The interobserver agreement of the PB was moderate and was improved by the DR review, as indicated by an increased κ value (0.59 vs 0.55), mean sensitivity (0.64 vs 0.58), volume of total agreement (3.9 vs 3.3 cm(3)), and decrease in the union volume (79.3 vs 84.2 cm(3)). Rectal and bladder wall DVH parameters of IMRT and VMAT vs 3D-CRT plans were not significantly different.
  
  
  CONCLUSIONS
  The interobserver agreement of PB delineation was moderate but was improved by the DR. Major deviations could be identified for the majority of centers. The DR has improved the acquaintance of the participating centers with the trial protocol.
authors: Department of Radiation Oncology and Division of Medical Radiation Physics, Bern University Hospital, Switzerland.
authors: Manfred
authors: M
authors: Sassowsky
authors: Philipp
authors: P
authors: Gut
authors: Tobias
authors: T
authors: Hölscher
authors: Guido
authors: G
authors: Hildebrandt
authors: Arndt-Christian
authors: AC
authors: Müller
authors: Yousef
authors: Y
authors: Najafi
authors: Götz
authors: G
authors: Kohler
authors: Helmut
authors: H
authors: Kranzbühler
authors: Matthias
authors: M
authors: Guckenberger
authors: Daniel R
authors: DR
authors: Zwahlen
authors: Ngwa C
authors: NC
authors: Azinwi
authors: Ludwig
authors: L
authors: Plasswilm
authors: Istvan
authors: I
authors: Takacs
authors: Christiane
authors: C
authors: Reuter
authors: Marcin
authors: M
authors: Sumila
authors: Peter
authors: P
authors: Manser
authors: Piet
authors: P
authors: Ost
authors: Dirk
authors: D
authors: Böhmer
authors: Christiane
authors: C
authors: Pilop
authors: Daniel M
authors: DM
authors: Aebersold
authors: Pirus
authors: P
authors: Ghadjar
mesh_terms: D000368:Aged; D002173:Cancer Care Facilities / Q000592:standards; D005060:Europe; D005270:Femur Head; D019983:Guideline Adherence / Q000592:standards*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D015588:Observer Variation; D058958:Organs at Risk / Q000000981:diagnostic imaging; D019047:Phantoms, Imaging; D011467:Prostate / Q000000981:diagnostic imaging; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D011785:Quality Assurance, Health Care / Q000592:standards; D058996:Quality Improvement / Q000592:standards*; D011859:Radiography; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods / Q000592:standards; D020266:Radiotherapy, Conformal / Q000379:methods / Q000592:standards*; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods / Q000592:standards; D012007:Rectum; D016879:Salvage Therapy / Q000379:methods / Q000592:standards*; D011795:Surveys and Questionnaires; D001743:Urinary Bladder
chemical_list: D017430:Prostate-Specific Antigen